Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Interneuronal δ-GABAA receptors regulate binge drinking and are necessary for the behavioral effects of early withdrawal.

Melón LC, Nasman JT, John AS, Mbonu K, Maguire JL.

Neuropsychopharmacology. 2018 Jul 28. doi: 10.1038/s41386-018-0164-z. [Epub ahead of print]

PMID:
30089884
2.

New Strategies for Expression and Purification of Recombinant Human RNASET2 Protein in Pichia pastoris.

Lualdi M, Pedrini E, Petroni F, Näsman J, Lindqvist C, Scaldaferri D, Taramelli R, Inforzato A, Acquati F.

Mol Biotechnol. 2015 Jun;57(6):513-25. doi: 10.1007/s12033-015-9845-6.

PMID:
25663099
3.

Enhanced early expression of membrane receptors with the Rous sarcoma virus promoter in baculovirus-infected insect cells.

Näreoja K, Akerman KE, Näsman J.

Biotechnol Appl Biochem. 2012 Jul-Aug;59(4):314-21. doi: 10.1002/bab.1029. Epub 2012 Jul 26.

PMID:
23586865
4.

Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling.

Jäntti MH, Putula J, Turunen PM, Näsman J, Reijonen S, Lindqvist C, Kukkonen JP.

Mol Pharmacol. 2013 Mar;83(3):621-32. doi: 10.1124/mol.112.080523. Epub 2012 Dec 11.

5.

Canonical transient receptor potential channel 2 (TRPC2) as a major regulator of calcium homeostasis in rat thyroid FRTL-5 cells: importance of protein kinase C δ (PKCδ) and stromal interaction molecule 2 (STIM2).

Sukumaran P, Löf C, Kemppainen K, Kankaanpää P, Pulli I, Näsman J, Viitanen T, Törnquist K.

J Biol Chem. 2012 Dec 28;287(53):44345-60. doi: 10.1074/jbc.M112.374348. Epub 2012 Nov 9.

6.

Communication between the calcium and cAMP pathways regulate the expression of the TSH receptor: TRPC2 in the center of action.

Löf C, Sukumaran P, Viitanen T, Vainio M, Kemppainen K, Pulli I, Näsman J, Kukkonen JP, Törnquist K.

Mol Endocrinol. 2012 Dec;26(12):2046-57. doi: 10.1210/me.2012-1171. Epub 2012 Sep 26.

7.

Characterization of α(2B)-adrenoceptor ligand binding in the presence of muscarinic toxin α and delineation of structural features of receptor binding selectivity.

Näreoja K, Näsman J.

Eur J Pharmacol. 2012 May 15;683(1-3):63-70. doi: 10.1016/j.ejphar.2012.03.028. Epub 2012 Mar 23.

PMID:
22465183
8.

Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein.

Rondinelli S, Näreoja K, Näsman J.

Toxins (Basel). 2011 Nov;3(11):1393-404. doi: 10.3390/toxins3111393. Epub 2011 Nov 11.

9.

Glycosylphosphatidylinositol (GPI)-anchoring of mamba toxins enables cell-restricted receptor silencing.

Näreoja K, Louhivuori LM, Akerman KE, Meriluoto J, Näsman J.

Biochem Biophys Res Commun. 2012 Jan 6;417(1):93-7. doi: 10.1016/j.bbrc.2011.11.062. Epub 2011 Nov 19.

PMID:
22138651
10.

Adrenoceptor activity of muscarinic toxins identified from mamba venoms.

Näreoja K, Kukkonen JP, Rondinelli S, Toivola DM, Meriluoto J, Näsman J.

Br J Pharmacol. 2011 Sep;164(2b):538-50. doi: 10.1111/j.1476-5381.2011.01468.x.

11.

Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction.

Putula J, Turunen PM, Johansson L, Näsman J, Ra R, Korhonen L, Kukkonen JP.

FEBS Lett. 2011 May 6;585(9):1368-74. doi: 10.1016/j.febslet.2011.04.020. Epub 2011 Apr 15.

12.

Selective targeting of G-protein-coupled receptor subtypes with venom peptides.

Näreoja K, Näsman J.

Acta Physiol (Oxf). 2012 Feb;204(2):186-201. doi: 10.1111/j.1748-1716.2011.02305.x. Epub 2011 May 7. Review.

PMID:
21481193
13.

Comparison of the baculovirus-insect cell and Pichia pastoris heterologous systems for the expression of the human tumor suppressor protein RNASET2.

Campomenosi P, Cinquetti R, Tallarita E, Lindqvist C, Raimondi I, Grassi P, Näsman J, Dell A, Haslam SM, Taramelli R, Acquati F.

Biotechnol Appl Biochem. 2011 Jan-Feb;58(1):39-49. doi: 10.1002/bab.7.

PMID:
21446958
14.

Selective interference with TRPC3/6 channels disrupts OX1 receptor signalling via NCX and reveals a distinct calcium influx pathway.

Louhivuori LM, Jansson L, Nordström T, Bart G, Näsman J, Akerman KE.

Cell Calcium. 2010 Aug-Sep;48(2-3):114-23. doi: 10.1016/j.ceca.2010.07.005. Epub 2010 Aug 21.

PMID:
20728215
15.

Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer.

Laatikainen LE, Castellone MD, Hebrant A, Hoste C, Cantisani MC, Laurila JP, Salvatore G, Salerno P, Basolo F, Näsman J, Dumont JE, Santoro M, Laukkanen MO.

Endocr Relat Cancer. 2010 Aug 16;17(3):785-96. doi: 10.1677/ERC-10-0021. Print 2010 Sep.

16.

The three-finger toxin MTalpha is a selective alpha(2B)-adrenoceptor antagonist.

Koivula K, Rondinelli S, Näsman J.

Toxicon. 2010 Sep 1;56(3):440-7. doi: 10.1016/j.toxicon.2010.05.001. Epub 2010 May 11.

PMID:
20466015
17.

Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells.

Louhivuori LM, Bart G, Larsson KP, Louhivuori V, Näsman J, Nordström T, Koivisto AP, Akerman KE.

J Cell Physiol. 2009 Oct;221(1):67-74. doi: 10.1002/jcp.21828.

PMID:
19507192
18.

Enhancement of agonist binding to 5-HT1A receptors in rat brain membranes by millimolar Mn2+.

Parkel S, Näsman J, Rinken A.

Neurosci Lett. 2009 Jun 19;457(1):32-5. doi: 10.1016/j.neulet.2009.04.002. Epub 2009 Apr 7.

PMID:
19429156
19.

The orexin OX1 receptor regulates Ca2+ entry via diacylglycerol-activated channels in differentiated neuroblastoma cells.

Näsman J, Bart G, Larsson K, Louhivuori L, Peltonen H, Akerman KE.

J Neurosci. 2006 Oct 18;26(42):10658-66.

20.

Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1.

Magga J, Bart G, Oker-Blom C, Kukkonen JP, Akerman KE, Näsman J.

Biochem Pharmacol. 2006 Mar 14;71(6):827-36. Epub 2006 Jan 20.

PMID:
16430869
21.

Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops.

Kukkonen A, Peräkylä M, Akerman KE, Näsman J.

J Biol Chem. 2004 Dec 3;279(49):50923-9. Epub 2004 Sep 27.

22.

Characterization of M2 muscarinic receptor activation of different G protein subtypes.

Uustare A, Näsman J, Akerman KE, Rinken A.

Neurochem Int. 2004 Jan;44(2):119-24.

PMID:
12971914
23.

The STC-1 cells express functional orexin-A receptors coupled to CCK release.

Larsson KP, Akerman KE, Magga J, Uotila S, Kukkonen JP, Näsman J, Herzig KH.

Biochem Biophys Res Commun. 2003 Sep 12;309(1):209-16.

PMID:
12943684
24.

Different roles for Gi and Go proteins in modulation of adenylyl cyclase type-2 activity.

Näsman J, Kukkonen JP, Holmqvist T, Akerman KE.

J Neurochem. 2002 Dec;83(6):1252-61.

25.

Dual signalling by different octopamine receptors converges on adenylate cyclase in Sf9 cells.

Näsman J, Kukkonen JP, Akerman KE.

Insect Biochem Mol Biol. 2002 Mar 1;32(3):285-93.

PMID:
11804800
26.

Modelling of promiscuous receptor-Gi/Gs-protein coupling and effector response.

Kukkonen JP, Näsman J, Akerman KE.

Trends Pharmacol Sci. 2001 Dec;22(12):616-22. Review.

PMID:
11730971
27.

Role of G-protein availability in differential signaling by alpha 2-adrenoceptors.

Nasman J, Kukkonen JP, Ammoun S, Akerman KE.

Biochem Pharmacol. 2001 Oct 1;62(7):913-22.

PMID:
11543726
28.

Recombinant expression of a selective blocker of M(1) muscarinic receptors.

Näsman J, Jolkkonen M, Ammoun S, Karlsson E, Akerman KE.

Biochem Biophys Res Commun. 2000 May 10;271(2):435-9.

PMID:
10799315
29.

Role of third intracellular loop of galanin receptor type 1 in signal transduction.

Rezaei K, Saar K, Soomets U, Valkna A, Näsman J, Zorko M, Akerman K, Schroeder T, Bartfai T, Langel U.

Neuropeptides. 2000 Feb;34(1):25-31.

PMID:
10688965
30.

Influence of ionic strength on drug adsorption onto and release from a poly(acrylic acid) grafted poly(vinylidene fluoride) membrane.

Akerman S, Svarfvar B, Kontturi K, Näsman J, Urtti A, Paronen P, Järvinen K.

Int J Pharm. 1999 Feb 1;178(1):67-75.

PMID:
10205626
31.

Alpha2B-adrenoceptors couple to Ca2+ increase in both endogenous and recombinant expression systems.

Holmberg CI, Kukkonen JP, Bischoff A, Näsman J, Courtney MJ, Michel MC, Akerman KE.

Eur J Pharmacol. 1998 Dec 11;363(1):65-74.

PMID:
9877083
32.

Endogenous extracellular purine nucleotides redirect alpha2-adrenoceptor signaling.

Akerman KE, Näsman J, Lund PE, Shariatmadari R, Kukkonen JP.

FEBS Lett. 1998 Jul 3;430(3):209-12.

33.

Transport of drugs across porous ion exchange membranes.

Akerman S, Viinikka P, Svarfvar B, Järvinen K, Kontturi K, Näsman J, Urtti A, Paronen P.

J Control Release. 1998 Jan 2;50(1-3):153-66.

PMID:
9685882
34.

Protean agonism at alpha2A-adrenoceptors.

Jansson CC, Kukkonen JP, Näsman J, Huifang G, Wurster S, Virtanen R, Savola JM, Cockcroft V, Akerman KE.

Mol Pharmacol. 1998 May;53(5):963-8.

35.

[3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine.

Uhlén S, Dambrova M, Näsman J, Schiöth HB, Gu Y, Wikberg-Matsson A, Wikberg JE.

Eur J Pharmacol. 1998 Feb 5;343(1):93-101.

PMID:
9551719
36.

Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists.

Kukkonen JP, Näsman J, Rinken A, Dementjev A, Akerman KE.

Biochem Biophys Res Commun. 1998 Feb 4;243(1):41-6.

PMID:
9473476
37.
38.

Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression system.

Kukkonen JP, Näsman J, Ojala P, Oker-Blom C, Akerman KE.

J Pharmacol Exp Ther. 1996 Nov;279(2):593-601.

PMID:
8930161
39.

Glass-ionomer cements based on poly(acrylic acid-co-vinyl alcohol) in drug release model formulations.

Lindsjö MC, Ekman KB, Näsman JH.

Biomaterials. 1996 May;17(9):913-9.

PMID:
8718937
40.
41.

Muscarinic receptor subtypes in human neuroblastoma cell lines SH-SY5Y and IMR-32 as determined by receptor binding, Ca++ mobilization and northern blotting.

Kukkonen J, Ojala P, Näsman J, Hämäläinen H, Heikkilä J, Akerman KE.

J Pharmacol Exp Ther. 1992 Dec;263(3):1487-93.

PMID:
1335069

Supplemental Content

Loading ...
Support Center